Stock analysts at Wells Fargo & Company began coverage on shares of Danaher Corporation (NYSE:DHR) in a research note issued on Thursday, MarketBeat Ratings reports. The brokerage set a “market perform” rating and a $90.00 price target on the conglomerate’s stock. Wells Fargo & Company’s price objective points to a potential upside of 5.88% from the stock’s current price.
Other equities research analysts have also recently issued research reports about the stock. Credit Suisse Group reaffirmed a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $96.00 price objective on the stock in a research note on Tuesday, April 4th. BTIG Research reaffirmed a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a research note on Sunday, April 23rd. Deutsche Bank AG reaffirmed a “buy” rating and set a $97.00 price objective on shares of Danaher Corporation in a research note on Wednesday, June 21st. Finally, BidaskClub raised shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, June 21st. Two research analysts have rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation has an average rating of “Buy” and a consensus price target of $92.11.
Danaher Corporation (DHR) traded up 0.86% during trading on Thursday, hitting $85.73. 464,423 shares of the company were exchanged. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01. The firm’s 50 day moving average price is $84.47 and its 200-day moving average price is $83.63. The stock has a market capitalization of $59.51 billion, a PE ratio of 26.13 and a beta of 1.05.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, April 20th. The conglomerate reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.01. The business had revenue of $4.21 billion for the quarter, compared to analysts’ expectations of $4.17 billion. Danaher Corporation had a net margin of 12.30% and a return on equity of 11.82%. The business’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $1.08 EPS. Equities analysts predict that Danaher Corporation will post $3.93 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be issued a dividend of $0.14 per share. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.66%. Danaher Corporation’s dividend payout ratio is presently 17.02%.
TRADEMARK VIOLATION NOTICE: This story was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/2722503/danaher-corporation-dhr-now-covered-by-wells-fargo-company.html.
In related news, Director Donald J. Ehrlich purchased 600 shares of Danaher Corporation stock in a transaction dated Friday, April 21st. The shares were acquired at an average price of $82.76 per share, for a total transaction of $49,656.00. Following the acquisition, the director now directly owns 84,800 shares in the company, valued at $7,018,048. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 82,265 shares of company stock worth $6,815,839. Insiders own 12.20% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of DHR. Israel Discount Bank of New York GFN bought a new position in Danaher Corporation during the fourth quarter valued at approximately $225,000. Vident Investment Advisory LLC raised its position in Danaher Corporation by 5.4% in the fourth quarter. Vident Investment Advisory LLC now owns 29,689 shares of the conglomerate’s stock valued at $2,311,000 after buying an additional 1,521 shares in the last quarter. Aristotle Capital Management LLC raised its position in Danaher Corporation by 4.5% in the fourth quarter. Aristotle Capital Management LLC now owns 2,771,135 shares of the conglomerate’s stock valued at $215,705,000 after buying an additional 119,978 shares in the last quarter. Norges Bank bought a new position in Danaher Corporation during the fourth quarter valued at approximately $465,363,000. Finally, Putnam Investments LLC raised its position in Danaher Corporation by 17.0% in the fourth quarter. Putnam Investments LLC now owns 3,721,935 shares of the conglomerate’s stock valued at $289,715,000 after buying an additional 540,529 shares in the last quarter. Institutional investors and hedge funds own 76.30% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.